Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 6, 2010, Pages 1153-1163

  Horn, Iris Susanne ^a   Wichmann, Gunnar ^a   Mozet, Christian ^a   Dietz, Andreas ^a   Dollner, Ralph ^b   Tschöp, Katrin ^a   Boehm, Andreas ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Epithelial cells; Ex vivo chemoresponse; Heterogeneity; HNSCC; Stromal cells

Indexed keywords

CISPLATIN; DOCETAXEL; METHANOL; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL HETEROGENEITY; CELL POPULATION; CHEMOREACTIVITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLONY FORMING CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EPITHELIUM CELL; EX VIVO STUDY; FEMALE; GIEMSA STAIN; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STROMA CELL; TUMOR CELL CULTURE; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL CELLS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; STROMAL CELLS; TAXOIDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 77951891649     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1124-4     Document Type: Article

References (37)

1. Wright JL, Cobb JP, Gumport SL, Golomb FM, Safadi D (1957) Investigation of the relation between clinical and tissue culture response to chemotherapeutic agents of human cancer. N Engl J Med 257:1207-1211
2. Di Paolo JA, Dowd JE (1961) Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test. J Natl Cancer Inst 27:807-815
3. Courtenay VD, Mills J (1978) An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37:261-268
4. Freeman AE, Ho Vman RM (1986) In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83:2694-2698
5. Vescio RA, Redfern CH, Nelson TJ, Ugoretz S, Stern PH, Ho Vmann RM (1987) In vivo-like drug responses of human tumors growing in three-dimensional, gel-supported, primary culture. Proc Natl Acad Sci USA 84:5029-5033
6. Vescio RA, Connors KM, Bordin GM, Robb JA, Youngkin T, Umbreit JN, Hoffmann RM (1990) The distinction of small cell and non-small cell lung cancer by growth in native-state histoculture. Cancer Res 50:6095-6099
7. Furukawa T, Kubota T, Watanabe M, Takahara T, Yamaguchi H, Kase S, Kodaira S, Ishibiki K, Kitajima M (1992) High in vitro correlation of drug response using sponge-gel-supported threedimensional histoculture and the MTT end point. Int J Cancer 51:489-498
8. Robbins KT, Varki NM, Storniolo AM, Hoffman H, Hoffman RM (1991) Drug response of head and neck tumors in native-state histoculture. Arch Otolaryngol Head Neck Surg 117:83-86
9. Von Hoff DD (1990) He's not going to talk about in vitro predictive assays again, is he? J Natl Cancer Inst 82:96-101
10. Dollner R, Granzow C, Werner JA, Dietz A (2004) Is there a role for chemosensitivity tests in head and neck cancer? Onkologie 27:310-315
11. Weisenthal LM, Lippman ME (1985) Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 69:615-632
12. Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (De LOS-I-trial). Eur Arch Otorhinolaryngol 266(8):1291-1300
13. Rajaraman R, Guernsey DL, Rajaraman MM, Rajaraman SR (2006) Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 6:25. doi:10.1186/1475-2867-6-25 (Pubitemid 44869912)
14. Rajamaran R, Rajaraman MM, Rajaraman SR, Guernsey DL (2005) Neosis: a paradigm of self-renewal in cancer. Cell Biol Int 29:1084-1097
15. Heuser M, Kopun M, Rittgen W, Granzow C (2005) Cytotoxicity determination without photochemical artifacts. Cancer Lett 223:57-66
16. Granzow C, Kopun M, Kröber T (1995) Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays. Cancer Res 55:4837-4843
17. Wichmann G, Horn I-S, Boehm A, Mozet C, Tschöp K, Dollner R, Dietz A (2009) Single biopsies from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel. Onkologie 32(5):264-272
18. Dietz A, Tschöp K, Wichmann G, Granzow C (2008) Method and kit for the ex vivo evaluation of the response of a tumor to conditions to be tested. US-Provisional Ser. No. 61/044, 082
19. Cabelguenne A, Blons H, Waziers De I, Carnot F, Houllier A-M, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P (2000) p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol 18:1465-1473
20. Fouret P, Temam S, Charlotte F, Lacau-St-Guily J (2002) Tumor stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumor response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck. Br J Cancer 87:1390-1395
21. Hoffmann TK, Sonkoly E, Hauser U, Lierop A, Whiteside TL, Klussmann JP, Hafner D, Schuler P, Friebe-Hoffmann U, Scheckenbach K, Erjala K, Gréman R, Schipper J, Bier H, Balz V (2008) Alterations in the p53 pathway and their association with radio-and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol 44(12):1100-1109
22. Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR (2004) Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Head Neck 26:870-877
23. American Joint Committee on Cancer: Comparison Guide: Cancer Staging Manual Fifth versus Sixth Edition. http://www.cancerstaging.org/products/ ajccguide.pdf. Accessed 31 March 2009
24. Dollner R, Kopun M, Dietz A, Wiessler M, Granzow C (2002) Chemoreactivity profiling of HNSCC: equipotentiality of platinum compounds and glufosfamide, a novel alkylating agent. Proc Am Assn Cancer Res 43:926-931
25. Dollner R, Granzow C, Helmke BM, Ruess A, Schad A, Dietz A (2004) The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma. Anticancer Res 24:325-331
26. Desoize B, Berthiot G, Manot L, Coninx P, Dumont P (1996) Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration. Eur J Cancer A 32:1734-1738
27. Bissett D, Setanoians A, Cassidy J, Graham MA, Chadwick GA, Wilson P, Auzannet V, Le Bail N, Kaye SB, Kerr DJ (1993) Phase I and pharmakokinetic study of Taxotere (RP 56976) administered as a 24-h infusion. Cancer Res 53:523-527 (Pubitemid 23059430)
28. Witz IP, Levy-Nissenbaum O (2006) The tumor microenvironment in the post-PAGET era. Cancer Lett 242:1-10
29. Freeman AE, Hoffman RM (1986) In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83:2694-2698
30. Dollner R, Granzow C, Neudert M, Dietz A (2006) Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations. Anticancer Res 26:1651-1655
31. Granzow C, Kopun M, Heuser M, Herth F, Becker HD (2004) Chemoresistance of human lung tumor stromal cells. Am Assn Cancer Res 95th Annual Meeting Proc Suppl. abstract LB-82
32. Hasegawa Y, Goto M, Hanai N, Ijichi K, Adachi M, Terada A, Hyodo I, Ogawa T, Furukawa T (2007) Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer. Oral Oncol 43:749-756
33. Singh B, Li R, Xu L, Poluri A, Patel S, Shaha AR, Pfister D, Sherman E, Goberdhan A, Hoffman RM, Shah J (2002) Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck 24:437-442
34. Mukaida H, Hirabayashi N, Hirai T, Iwata T, Saeki S, Toge T (1991) Significance of freshly cultured fibroblasts from different tissues in promoting cancer cell growth. Int J Cancer 48:423-427
35. Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL (2006) Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 6:52
36. Rosenthal EL, McCrory A, Talbert M, Carroll W, Magnuson JS, Peters GE (2004) Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. Arch Otolaryng Head Nack Surg 130:943-947 (Pubitemid 39045601)
37. Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P (2000) The effect of fibroblast growth factor 8, isoform b, on the biology of prostata carcinoma cells and their interaction with stromal cells. Cancer Res 60:6730-6736